PREAMBLE Our mission was to develop evidence-based guidelines for the prevention and
treatment of perioperative/postoperative atrial fibrillation and flutter (POAF) for thoracic …

Atrial fibrillation (AF) has been found to occur with an increased frequency in patients with
malignancies, particularly in those undergoing cancer surgery. The occurrence of AF in …

Background and Purpose—Although believed to be transient and self-limiting, new-onset
perioperative/postoperative atrial fibrillation (POAF) might be a risk factor for stroke and …

Purpose New-onset atrial fibrillation (NOAF) is common and associated with increased
morbidity and mortality. However, its clinical importance and management in critically ill …

An increasing body of evidence suggests an association between cancer and atrial
fibrillation (AF). The exact magnitude and underlying mechanism of this association are …

Atrial fibrillation (AF) is common in patients with life-threatening cancer and those
undergoing active cancer treatment. However, data from subjects with a history of non–life …

Cardiac toxicities from cancer therapy can become evident many years after treatment, and
these late cardiac effects can have a profound impact on cancer survivors. There are a …

Background: Postoperative atrial fibrillation (POAF) is a frequent occurrence after
noncardiac surgery. It remains unclear whether POAF is associated with an increased risk of …

Cancer patients are at an increased risk of developing atrial fibrillation (AF) and thrombosis.
However, the management of anticoagulation in patients with both diseases may be …

Although thoracic surgery is understood to confer a high risk of postoperative respiratory
complications, the substantial haemodynamic challenges posed are less well appreciated …